In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer

Ali, 2014, Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients, Ann. Oncol., 25, 1536, 10.1093/annonc/mdu191 Alkatout, 2008, Prowling wolves in sheep's clothing: the search for tumor stem cells, Biol. Chem., 389, 799, 10.1515/BC.2008.094 Alkatout, 2013, Surgical impact of new treatments in breast cancer, Minerva Ginecol., 65, 363 Alkatout, 2013, Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer, Exp. Mol. Pathol., 94, 168, 10.1016/j.yexmp.2012.09.003 Baldassarre, 2016, Molecular biology of breast tumors and prognosis, F1000Res., 5, 10.12688/f1000research.8158.1 Baritaki, 2010, Viral infection and cancer: the NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes, Crit. Rev. Immunol., 30, 31, 10.1615/CritRevImmunol.v30.i1.20 DeNardo, 2008, Immune cells as mediators of solid tumor metastasis, Cancer Metastasis Rev., 27, 11, 10.1007/s10555-007-9100-0 Elloul, 2005, Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma, Cancer, 103, 1631, 10.1002/cncr.20946 Gerlinger, 2012, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N. Engl. J. Med., 366, 883, 10.1056/NEJMoa1113205 Jiang, 2015, Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis, BMC Cancer, 15, 727, 10.1186/s12885-015-1742-7 Kudo-Saito, 2009, Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells, Cancer Cell, 15, 195, 10.1016/j.ccr.2009.01.023 Liu, 2011, CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes, Breast Cancer Res. Treat., 130, 645, 10.1007/s10549-011-1647-3 Liu, 2012, CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer, Breast Cancer Res., 14, R48, 10.1186/bcr3148 Logullo, 2010, Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression, Oncol. Rep., 23, 313 Loi, 2013, Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98, J. Clin. Oncol., 31, 860, 10.1200/JCO.2011.41.0902 Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 Mao, 2016, The prognostic value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis, PLoS One, 11, 10.1371/journal.pone.0152500 Miyashita, 2015, Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study, Breast Cancer Res., 17, 124, 10.1186/s13058-015-0632-x Nassar, 2010, Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study, Appl. Immunohistochem. Mol. Morphol., 18, 433, 10.1097/PAI.0b013e3181dddb20 Nomura, 2013, Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis, BMC Urol., 13, 73, 10.1186/1471-2490-13-73 Ohshio, 2013, Inhibition of transforming growth factor-beta release from tumor cells reduces their motility associated with epithelial-mesenchymal transition, Oncol. Rep., 30, 1000, 10.3892/or.2013.2505 Rathore, 2013, Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast, Indian J. Cancer, 50, 239, 10.4103/0019-509X.118744 Rathore, 2014, CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast, Indian J. Med. Res., 140, 361 Salgado, 2015, The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014, Ann. Oncol., 26, 259, 10.1093/annonc/mdu450 Schmalhofer, 2009, E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer, Cancer Metastasis Rev., 28, 151, 10.1007/s10555-008-9179-y Shah, 2012, The clonal and mutational evolution spectrum of primary triple-negative breast cancers, Nature, 486, 395, 10.1038/nature10933 Stanton, 2016, Clinical significance of tumor-infiltrating lymphocytes in breast cancer, J Immunother Cancer., 4, 59, 10.1186/s40425-016-0165-6 Tan, 2014, Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients, EMBO Mol Med., 6, 1279, 10.15252/emmm.201404208 Thiery, 2002, Epithelial-mesenchymal transitions in tumour progression, Nat. Rev. Cancer, 2, 442, 10.1038/nrc822 Vincent, 2009, A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition, Nat. Cell Biol., 11, 943, 10.1038/ncb1905 West, 2011, Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer, Breast Cancer Res., 13, R126, 10.1186/bcr3072 Wodarz, 2007, Cell polarity in development and cancer, Nat. Cell Biol., 9, 1016, 10.1038/ncb433